A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women

NCT00000744 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

400

Enrollment

NIH

Sponsor class

Conditions

Candidiasis
Candidiasis, Esophageal
HIV Infections

Interventions

DRUG: Fluconazole

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]